Author

S. M. Shin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Assay:flow cytometry· 1

Frequent Co-Authors

A. Hernandez· 2 shared E. M. Coyne· 2 shared J. W. Lee· 2 shared M. Yarchoan· 2 shared W. J. Ho· 2 shared A. Girgis· 1 shared A. Gregory· 1 shared A. L. Huff· 1 shared

Activity by Year

2023-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 32 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Hernandez

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

PhysiologybioRxivPreprintDec 4, 2023

Role of Dusp5 KO on Vascular Properties of Middle Cerebral Artery in Rats

C. Tang, H. Zhang, J. J. Border…·F. Fan

This study examines the structural and mechanical properties of the middle cerebral artery in Dusp5 KO rats, finding limited structural changes but enhanced myogenic tone, suggesting Dusp5's role in hemodynamics and cognition is enzyme-driven.

DOI 10.1101/2023.12.04.569939

ratexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintOct 20, 2023

Liver fibrosis uncouples tumor control from survival after multikinase inhibitor immunotherapy in hepatocellular carcinoma

S. Morita, T. Ando, H. Kikuchi…·D. G. Duda

Liver fibrosis limits the survival benefit of multikinase inhibitor immunotherapy in hepatocellular carcinoma by promoting innate immune-mediated hepatotoxicity despite preserved tumor control.

DOI 10.1101/2023.10.20.563378

mousehuman

𝕏 PostBluesky

ImmunologybioRxivPreprintOct 16, 2023

Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade

D. H. Shu, W. J. Ho, L. T. Kagohara…·M. Yarchoan

This study examines TLS in HCC treated with neoadjuvant immunotherapy, finding TLS correlate with better outcomes and show distinct morphological and functional features in tumor regression.

DOI 10.1101/2023.10.16.562104

humanbulk RNA-seq

𝕏 PostBluesky